Skip to content

Opening book details…

About this Medicine article

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial by Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; Robert C. Welsh; Robert G. Wilcox; Jeffrey A. Bakal is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; Robert C. Welsh; Robert G. Wilcox; Jeffrey A. Bakal
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6744)
Published
2011
Field
Medicine (Health Sciences)

More by Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; Robert C. Welsh; Robert G. Wilcox; Jeffrey A. Bakal

Browse all works by Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; Robert C. Welsh; Robert G. Wilcox; Jeffrey A. Bakal